drugset / Trial / NCT00553878
Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer
RandomizedSingle-groupDouble-blindPrevention
Summary
Patient on an intermittent androgen deprivation protocol for biochemical recurrence after radical local therapy for prostate cancer,the addition of continuous dutasteride treatment, significantly prolongs the duration of the off treatment interval and time to androgen independence.
Timeline
- Start
- 2007-03
- Primary completion
- 2009-09
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dutasteride | Small molecule | 0.5 mg | Oral |